The Authors Reply: Coyne and colleagues cite one metaanalysis of diagnostic validation studies but proffer a more negative interpretation than the authors who concluded that "the PHQ9 has good diagnostic properties, and was able to correctly diagnose major depression (sensitivity 92%) while being able to exclude this condition with some certainty (specificity 80%)" 1 . A second PHQ-9 meta-analysis found 77% sensitivity and 94% specificity 2 . In a review of case-finding instruments in primary care, the PHQ-9 had operating characteristics comparable to longer depression measures 3 . Other
features of the PHQ-9 have contributed to its popularity, including its brevity, its focus on the nine core symptoms of DSM-IV depressive disorders, its sensitivity to change, its robust performance across different race/ethnic groups, its translation into more than 70 languages, and its nonproprietary nature.
We agree with the authors on several points. First, by using the PHQ-9 diagnostic algorithm to determine sensitivity and specificity, the operating characteristics of the PHQ-2 in our particular study may have been inflated. It should be noted, however, that agreement even among mental health professionals using criterion standard diagnostic interviews is only modest 4 . Second, we agree that the use of the PHQ-9 or any depression measure must be coupled with a clinical interview to confirm diagnosis of a depressive disorder and to assess severity, duration, and functional impairment. Third, we agree that depression detection is warranted only if systems are in place to assure effective treatment and follow-up 5 . However, this is no different than any other chronic disease: measuring serum glucose, blood pressure, or lipids in the absence of effective diagnosis, treatment and follow-up would be a fruitless endeavor. Our AMPATH clinics in western Kenya provide comprehensive services. Fourth, we concur that ultra-brief measures like the PHQ-2 should not be used in isolation: a high score on the PHQ-2 should trigger completion of the full PHQ-9 as well as a clinical interview. While PHQ-9 test-retest reliability (0.59) was moderate, we stated this "may be acceptable" because two major events occurring during the interval could have slightly affected "true" depression scores for some participants-a tumultuous national two-day holiday to allow travel to a national election with several reports of civil unrest-and some (not all) participants attended a support group therapy session.
Finally, we acknowledged that future psychometric studies are needed in this population, including comparisons of PHQ-9 and PHQ-2 with gold standard diagnostic interviews. However, given that our study showed construct validity with general health ratings, content validity in which focus groups indicated the PHQ-9 was generally well understood but might benefit from two potential minor modifications to its instructions, high factor loadings, a pattern of item means similar to US validation samples, high internal consistency, and moderate test-retest reliability, we believe our conclusion that the PHQ-9 and PHQ-2 "appear to be" valid and reliable is warranted.
